Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide

Christian Federau, Soren Christensen, Zungho Zun, Sun-Won Park, Wendy Ni, Michael Moseley, Greg Zaharchuk

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Introduction: The goal of this study was to assess the changes in arterial spin labeling (ASL) cerebral blood flow (CBF) and arterial transit time (ATT), and in apparent diffusion coefficient (ADC), before and after an acetazolamide challenge in moyamoya patients, as function of arterial stenosis severity. Methods: Pre-operative patients diagnosed with moyamoya disease who could undergo MRI at 3.0T were recruited for this study. A multi-delay pseudo-continuous ASL and a diffusion-weighted sequence were acquired before and 15 min after acetazolamide injection. The severity of anterior, middle, and posterior cerebral artery pathology was graded on time-of-flight MR angiographic images. CBF, ATT, and ADC were measured on standardized regions of interest as function of the vessel stenosis severity. Results: Thirty patients were included. Fifty-four percent of all vessels were normal, 28% mildly/moderately stenosed, and 18% severely stenosed/occluded. Post-acetazolamide, a significantly larger CBF (ml/100 g/min) increase was observed in territories of normal (+19.6 ± 14.9) compared to mildly/moderately stenosed (+14.2 ± 27.2, p = 0.007), and severely stenosed/occluded arteries (+9.9 ± 24.2, p < 0.0001). ATT was longer in territories of vessel anomalies compared with normal regions at baseline. ATT decreases were observed in all territories post-acetazolamide. ADC did not decrease after acetazolamide in any regions, and no correlation was found between ADC changes and baseline ATT, change in ATT, or CVR. Conclusion: The hemodynamic response in moyamoya disease, as measured with ASL CBF, is impaired mostly in territories with severe arterial stenosis/occlusion, while ATT was prolonged in all non-normal regions. No significant changes in ADC were observed after acetazolamide.

Original languageEnglish
Pages (from-to)5-12
Number of pages8
JournalNeuroradiology
Volume59
Issue number1
DOIs
StatePublished - 1 Jan 2017

Fingerprint

Cerebrovascular Circulation
Moyamoya Disease
Acetazolamide
Pathologic Constriction
Posterior Cerebral Artery
Anterior Cerebral Artery
Middle Cerebral Artery
Arteries
Hemodynamics
Pathology
Injections

Keywords

  • Acetazolamide challenge
  • Apparent diffusion coefficient
  • Arterial spin labeling
  • Cerebral blood flow
  • Moyamoya disease

Cite this

Federau, Christian ; Christensen, Soren ; Zun, Zungho ; Park, Sun-Won ; Ni, Wendy ; Moseley, Michael ; Zaharchuk, Greg. / Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide. In: Neuroradiology. 2017 ; Vol. 59, No. 1. pp. 5-12.
@article{8383ff1b4c8e46b6822a27bb016f86a8,
title = "Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide",
abstract = "Introduction: The goal of this study was to assess the changes in arterial spin labeling (ASL) cerebral blood flow (CBF) and arterial transit time (ATT), and in apparent diffusion coefficient (ADC), before and after an acetazolamide challenge in moyamoya patients, as function of arterial stenosis severity. Methods: Pre-operative patients diagnosed with moyamoya disease who could undergo MRI at 3.0T were recruited for this study. A multi-delay pseudo-continuous ASL and a diffusion-weighted sequence were acquired before and 15 min after acetazolamide injection. The severity of anterior, middle, and posterior cerebral artery pathology was graded on time-of-flight MR angiographic images. CBF, ATT, and ADC were measured on standardized regions of interest as function of the vessel stenosis severity. Results: Thirty patients were included. Fifty-four percent of all vessels were normal, 28{\%} mildly/moderately stenosed, and 18{\%} severely stenosed/occluded. Post-acetazolamide, a significantly larger CBF (ml/100 g/min) increase was observed in territories of normal (+19.6 ± 14.9) compared to mildly/moderately stenosed (+14.2 ± 27.2, p = 0.007), and severely stenosed/occluded arteries (+9.9 ± 24.2, p < 0.0001). ATT was longer in territories of vessel anomalies compared with normal regions at baseline. ATT decreases were observed in all territories post-acetazolamide. ADC did not decrease after acetazolamide in any regions, and no correlation was found between ADC changes and baseline ATT, change in ATT, or CVR. Conclusion: The hemodynamic response in moyamoya disease, as measured with ASL CBF, is impaired mostly in territories with severe arterial stenosis/occlusion, while ATT was prolonged in all non-normal regions. No significant changes in ADC were observed after acetazolamide.",
keywords = "Acetazolamide challenge, Apparent diffusion coefficient, Arterial spin labeling, Cerebral blood flow, Moyamoya disease",
author = "Christian Federau and Soren Christensen and Zungho Zun and Sun-Won Park and Wendy Ni and Michael Moseley and Greg Zaharchuk",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/s00234-016-1766-y",
language = "English",
volume = "59",
pages = "5--12",
journal = "Neuroradiology",
issn = "0028-3940",
publisher = "Springer Verlag",
number = "1",

}

Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide. / Federau, Christian; Christensen, Soren; Zun, Zungho; Park, Sun-Won; Ni, Wendy; Moseley, Michael; Zaharchuk, Greg.

In: Neuroradiology, Vol. 59, No. 1, 01.01.2017, p. 5-12.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide

AU - Federau, Christian

AU - Christensen, Soren

AU - Zun, Zungho

AU - Park, Sun-Won

AU - Ni, Wendy

AU - Moseley, Michael

AU - Zaharchuk, Greg

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Introduction: The goal of this study was to assess the changes in arterial spin labeling (ASL) cerebral blood flow (CBF) and arterial transit time (ATT), and in apparent diffusion coefficient (ADC), before and after an acetazolamide challenge in moyamoya patients, as function of arterial stenosis severity. Methods: Pre-operative patients diagnosed with moyamoya disease who could undergo MRI at 3.0T were recruited for this study. A multi-delay pseudo-continuous ASL and a diffusion-weighted sequence were acquired before and 15 min after acetazolamide injection. The severity of anterior, middle, and posterior cerebral artery pathology was graded on time-of-flight MR angiographic images. CBF, ATT, and ADC were measured on standardized regions of interest as function of the vessel stenosis severity. Results: Thirty patients were included. Fifty-four percent of all vessels were normal, 28% mildly/moderately stenosed, and 18% severely stenosed/occluded. Post-acetazolamide, a significantly larger CBF (ml/100 g/min) increase was observed in territories of normal (+19.6 ± 14.9) compared to mildly/moderately stenosed (+14.2 ± 27.2, p = 0.007), and severely stenosed/occluded arteries (+9.9 ± 24.2, p < 0.0001). ATT was longer in territories of vessel anomalies compared with normal regions at baseline. ATT decreases were observed in all territories post-acetazolamide. ADC did not decrease after acetazolamide in any regions, and no correlation was found between ADC changes and baseline ATT, change in ATT, or CVR. Conclusion: The hemodynamic response in moyamoya disease, as measured with ASL CBF, is impaired mostly in territories with severe arterial stenosis/occlusion, while ATT was prolonged in all non-normal regions. No significant changes in ADC were observed after acetazolamide.

AB - Introduction: The goal of this study was to assess the changes in arterial spin labeling (ASL) cerebral blood flow (CBF) and arterial transit time (ATT), and in apparent diffusion coefficient (ADC), before and after an acetazolamide challenge in moyamoya patients, as function of arterial stenosis severity. Methods: Pre-operative patients diagnosed with moyamoya disease who could undergo MRI at 3.0T were recruited for this study. A multi-delay pseudo-continuous ASL and a diffusion-weighted sequence were acquired before and 15 min after acetazolamide injection. The severity of anterior, middle, and posterior cerebral artery pathology was graded on time-of-flight MR angiographic images. CBF, ATT, and ADC were measured on standardized regions of interest as function of the vessel stenosis severity. Results: Thirty patients were included. Fifty-four percent of all vessels were normal, 28% mildly/moderately stenosed, and 18% severely stenosed/occluded. Post-acetazolamide, a significantly larger CBF (ml/100 g/min) increase was observed in territories of normal (+19.6 ± 14.9) compared to mildly/moderately stenosed (+14.2 ± 27.2, p = 0.007), and severely stenosed/occluded arteries (+9.9 ± 24.2, p < 0.0001). ATT was longer in territories of vessel anomalies compared with normal regions at baseline. ATT decreases were observed in all territories post-acetazolamide. ADC did not decrease after acetazolamide in any regions, and no correlation was found between ADC changes and baseline ATT, change in ATT, or CVR. Conclusion: The hemodynamic response in moyamoya disease, as measured with ASL CBF, is impaired mostly in territories with severe arterial stenosis/occlusion, while ATT was prolonged in all non-normal regions. No significant changes in ADC were observed after acetazolamide.

KW - Acetazolamide challenge

KW - Apparent diffusion coefficient

KW - Arterial spin labeling

KW - Cerebral blood flow

KW - Moyamoya disease

UR - http://www.scopus.com/inward/record.url?scp=85000979443&partnerID=8YFLogxK

U2 - 10.1007/s00234-016-1766-y

DO - 10.1007/s00234-016-1766-y

M3 - Article

C2 - 27913820

AN - SCOPUS:85000979443

VL - 59

SP - 5

EP - 12

JO - Neuroradiology

JF - Neuroradiology

SN - 0028-3940

IS - 1

ER -